Ultragenyx (RARE) revenue breakdown
By product, Product sales is the largest at 55% of fiscal 2025 revenue, growing 130% a year over 8 years.
By region, North America is the largest at 56% of fiscal 2025 revenue; Latin America grew fastest, 113% a year over 7 years.
Revenue by product
Fiscal years, as Ultragenyx reports them in its 10-K filings; fiscal 2025 total $673M.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Product sales | $476,000 | $10M | $20M | $39M | $77M | $119M | $180M | $285M | $369M | 55% |
| Royalty | — | — | — | $13M | $18M | $22M | $183M | $275M | $304M | 45% |
| Collaboration and license | — | — | — | — | — | — | $71M | — | — | — |
| Collaboration and license | $2M | $42M | $83M | $219M | $256M | $223M | — | — | — | — |
Revenue by region
Fiscal years, as Ultragenyx reports them in its 10-K filings; fiscal 2025 total $673M.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | $2M | $45M | $86M | $238M | $301M | $281M | $307M | $340M | $377M | 56% |
| Latin America | — | $863,000 | $5M | $12M | $24M | $45M | $77M | $131M | $170M | 25% |
| Europe, Middle East, and Africa | $323,000 | $5M | $12M | $21M | $27M | $36M | $48M | $80M | $108M | 16% |
| Asia-Pacific | — | — | — | — | — | $1M | $2M | $9M | $18M | 3% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for RARE.
Open RARE in InvestinglyQuestions
Where does Ultragenyx make its money?
In fiscal 2025, by product: Product sales $369M, Royalty $304M.
From Ultragenyx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.